...
机译:乳腺癌中激素受体的免疫组织化学评估:实用的评估系统和处理方案
Department of Pathology Tokai University School of Medicine Japan;
Department of Pathology Saitama Cancer Center Japan;
Department of Pathology Tohoku University Hospital Japan;
Department of Pathology Dokkyo University School of Medicine Japan;
Department of Anatomical Pathology Hiroshima University Hospital Japan;
Oncology and Immunology Nagoya City University Graduate School of Medical Sciences Japan;
Departmeni of Pathology Faculty of Medicine Kagoshima University Japan;
Department of Surgery Osaka Medical Center for Cancer and Cardiovascular Diseases Japan;
Department of Medical Oncology National Cancer Center Hospital Japan;
Department of Surgery Kyorin University School of Medicine Japan;
Department of Pathology Tokai University School of Medicine Japan;
Department of Pathology Cancer Institute Ariake Hospital Japan;
Hormone receptors; Immunohistochemistry; Evaluation system; Working protocol;
机译:乳腺癌中激素受体的免疫组织化学评估:哪种评分系统适用于高度敏感的手术?
机译:乳腺癌女性激素受体阳性和HER2过表达的免疫组织化学评价
机译:固定,加工和评估标准对乳腺癌激素受体免疫组织化学检测的影响
机译:使用微FTIR图像评估乳腺癌激素受体分类的机器学习模型
机译:开发了一种评估乳腺癌中胰岛素受体和胰岛素样生长因子-1受体同型二聚体和杂合受体的可靠方法。
机译:免疫组化激素受体表达的分级评估可增强以他莫昔芬为辅助治疗的乳腺癌患者的预后预测
机译:雌激素和孕酮受体在乳腺癌中的作用 - 雌激素和孕酮受体表达在女性侵袭性乳腺癌中的免疫组化评价